Covered recipient · General Payments record
MANUEL GARCIA-SMESTER
General Payments · PY2022–2025
$789.36
- Reported across 22 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $679.18 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $338.87 | 10 |
| Amgen Inc. | $185.48 | 5 |
| Janssen Biotech, Inc. | $140.15 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
Program year 2025 202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $46.92 | 02/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201901995 | CMS |
| ABBVIE INC. | $51.75 | 04/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201901997 | CMS |
| ABBVIE INC. | $16.84 | 09/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201901999 | CMS |
| ABBVIE INC. | $25.09 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201902001 | CMS |
| ABBVIE INC. | $18.28 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201902003 | CMS |
| ABBVIE INC. | $18.05 | 11/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201902005 | CMS |
| ABBVIE INC. | $3.93 | 11/26/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201902007 | CMS |
| ABBVIE INC. | $25.41 | 12/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201902009 | CMS |
| ABBVIE INC. | $125.00 | 12/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201902011 | CMS |
| ABBVIE INC. | $7.60 | 12/22/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201902013 | CMS |
| Amgen Inc. | $117.88 | 03/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228577943 | CMS |
| Amgen Inc. | $18.30 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228577945 | CMS |
| Amgen Inc. | $20.54 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228577939 | CMS |
| Amgen Inc. | $23.43 | 11/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228577937 | CMS |
| Amgen Inc. | $5.33 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227093033 | CMS |
| Janssen Biotech, Inc. | $15.15 | 10/29/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174267548 | CMS |
| Janssen Biotech, Inc. | $125.00 | 12/19/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1174267270 | CMS |
| Novartis Pharmaceuticals Corporation | $14.68 | 11/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200217165 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.